Trial 1: Clinical Trial with Advair HFA 45 mcg/21 mcg A placebo-controlled, 12-week, US trial compared Advair HFA 45 mcg/21 mcg with fluticasone propionate CFC inhalation aerosol 44 mcg or ...

The FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory diseases inhaler, after years of delays. Even though Advair’s main patent expired in 2010 and ...

Approved in asthma and COPD, Advair is still bringing in around £750 million every quarter, with around 45% of those sales based in the US. GSK’s new CEO Emma Walmsley has said that earnings ...